Machine learning and cancer survival: analysis of the Registro Hospitalar de Câncer do Estado de São Paulo
Fernando Henrique de Albuquerque Maia1, Lucas Buk Cardoso2, Simone Aldrey Angelo1
1Universidade de São Paulo. Faculdade de Saúde Pública. Departamento de Epidemiologia. São Paulo, SP, Brasil.
Objective:
To compare the performance of different Survival Machine Learning (SML) algorithms in predicting the survival of cancer patients.
Methods:
Data from the Registro Hospitalar de Câncer do Estado de São Paulo (São Paulo State Cancer Registry Hospital) were used, covering the five most incident types of cancer (breast, prostate, lung, colorectal and cervix). Six algorithms were evaluated: Gradient Boosting Survival (GBS), Random Survival Forest (RSF), Support Vector Machine Survival (SVM-Survival), XGBoost Cox, XGBoost Accelerated Failure Time (AFT), and LightGBM. Performance was measured by the Concordance Index (C-Index), C-Index IPCW and Integrated Brier Score (IBS) metrics.
Results:
The XGBoost AFT model showed the best C-Index results for breast (0.7845), lung (0.7368), colorectal (0.7618), and cervix (0.7726), while GBS was superior for prostate (0.7574). Clinical staging was consistently the most important variable, according to the explainability analysis.
Conclusion:
The SML algorithms showed good predictive performance, regardless of cancer type, sample size and censoring proportion. These models show potential for subsidizing cancer planning and supporting strategic decisions in the organization of cancer care networks.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Kaplan-Meier Approach
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

